WUXI APPTEC H 02359 YC1WUXI APPTEC H 02359 YC1WUXI APPTEC H 02359 YC1

WUXI APPTEC H 02359 YC1

No trades
See on Supercharts

WX8 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
WX8 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company